Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Amiot

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|May 2, 2013
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myelomaS Maïga, P Gomez-Bougie, S Bonnaud, et al.
Journal of Immunological Methods|July 12, 1994
A highly sensitive quantitative bioassay for human interleukin-11Z Y Lu, X G Zhang, Z J Gu, et al.
Blood|July 9, 1999
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cellsG Jego, N Robillard, D Puthier, et al.
Blood|December 15, 1996
Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasoneD Puthier, R Bataille, S Barillé, et al.
Blood|October 15, 1994
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cellsC Pellat-Deceunynck, R Bataille, N Robillard, et al.
Blood Cancer Journal|November 26, 2013
Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary diseaseL Lodé, P Moreau, A Ménard, et al.
Blood Reviews|March 13, 2017
p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hellB Tessoulin, M Eveillard, A Lok, et al.
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
British Journal of Cancer|November 11, 2010
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myelomaL Bodet, E Ménoret, G Descamps, et al.
British Journal of Cancer|February 1, 1990
K20 and ICO-10 monoclonal antibodies (gp120/200; Thy-1): immunophenotyping of human solid tumoursZ G Kadagidze, N N Tupitsyn, A J Baryshnikov, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|May 2, 2013
Paradoxical effect of lenalidomide on cytokine/growth factor profiles in multiple myelomaS Maïga, P Gomez-Bougie, S Bonnaud, et al.
Journal of Immunological Methods|July 12, 1994
A highly sensitive quantitative bioassay for human interleukin-11Z Y Lu, X G Zhang, Z J Gu, et al.
Blood|July 9, 1999
Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cellsG Jego, N Robillard, D Puthier, et al.
Blood|December 15, 1996
Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasoneD Puthier, R Bataille, S Barillé, et al.
Blood|October 15, 1994
Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cellsC Pellat-Deceunynck, R Bataille, N Robillard, et al.
Blood Cancer Journal|November 26, 2013
Lack of BRAF V600E mutation in human myeloma cell lines established from myeloma patients with extramedullary diseaseL Lodé, P Moreau, A Ménard, et al.
Blood Reviews|March 13, 2017
p53 dysregulation in B-cell malignancies: More than a single gene in the pathway to hellB Tessoulin, M Eveillard, A Lok, et al.
Leukemia|February 16, 2011
Phase I study of the anti insulin-like growth factor 1 receptor (IGF-1R) monoclonal antibody, AVE1642, as single agent and in combination with bortezomib in patients with relapsed multiple myelomaP Moreau, F Cavallo, X Leleu, et al.
British Journal of Cancer|November 11, 2010
BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myelomaL Bodet, E Ménoret, G Descamps, et al.
British Journal of Cancer|February 1, 1990
K20 and ICO-10 monoclonal antibodies (gp120/200; Thy-1): immunophenotyping of human solid tumoursZ G Kadagidze, N N Tupitsyn, A J Baryshnikov, et al.
Pageof 8